FB102 Commercial Lead
argenx
This listing was originally posted on argenx's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Drug products linked to this role
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moJoin us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
argenx is a global immunology company developing innovative potential therapies to help improve the lives of people suffering from severe autoimmune diseases. Our global team across Boston, Ghent, Japan, Canada, broader Europe and Emerging markets are committed to living by our values of co-creation, empowerment, humility, innovation and excellence. As we continue to expand our therapeutic franchises (ie neuromuscular, rheumatology, dermatology and nephrology) we remain science-based, data-driven and patient-focused. We listen to those we aim to serve, so we can best integrate their goals and aspirations into our work on their behalf. It is an exciting time to join this growth company.
The FB102 Lead is accountable for the commercial development and launch preparations for FB102, a first-in-class anti-CD122 (IL-2Rβ) monoclonal antibody originally developed by Forte Biosciences and acquired by argenx in 2026. It is aimed to be a portfolio in a product with potential in multiple indications such as vitiligo, celiac disease, and alopecia. In this senior leadership role, you will be a key member on the Global FB102 Asset team. You will collaborate across all domains of expertise, geographies and business units to create and deliver integrated strategic plans to optimize the value of our FB102 asset. You will serve as the commercial voice on the asset team and set commercial strategy for the asset.
Roles and Responsibilities:
Skills and Competencies:
Education, Experience and Qualifications:
#LI-remote
This job is eligible to participate in our short-term and long-term incentive programs, subject to the terms and conditions of those plans and applicable policies. It also includes a comprehensive benefits package, including but not limited to retirement savings plans, health benefits and other benefits subject to the terms of the applicable plans and program guidelines.
At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.
Before you submit your application, CV or any other personal details to us, please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates (“argenx”) will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights, please contact our Global Privacy Office by email at privacy@argenx.com.
If you require reasonable accommodation in completing your application, interviewing, or otherwise participating in the candidate selection process please contact us at hr.us@argenx.com. Only inquiries related to an accommodation request will receive a response.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at argenx?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Antibody therapies
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo